Tomer Gold

Vice President, Research & Development
Chemical Engineering and Biomedical Engineering
Dexcel Pharma
Israel

Business Expert Chemical Engineering
Biography

Tomer Gold has served as Vice President of Research & Development at Dexcel Pharma since 2011. He oversees more than 120 scientists and engineers, with responsibilities in the development, registration and launching of the company’s generic and innovative products. Prior to joining Dexcel, Mr. Gold led the Pharmaceutical Development – European Union team of the Global Generic Research and Development Group at Teva Pharmaceuticals. Mr. Gold holds a BSc in Chemical Engineering and an MSc in Biomedical Engineering from the Technion-Israel Institute of Technology.

Research Intrest

Global Generic Research and Development